Pharmaceuticals
Foreign competitors may outbid Polfa in local takeover
International drug-makers are almost certain to outbid top Polish pharmaceutical company Polfa Kutno in its attempt to buy a stake in publicly traded Jelfa ointment maker from the government. Polfa offered to pay 49 zloty per share in a 100-million zloty bid for 30 percent stake in Jelfa. Analysts now say the other five bidders, who include Israeli Teva, US-based Ivax and Italy?s Recordati could pay as much as 70 zloty per share for the company. Jelfa?s stock now trades at just over 60 zloty per share.
Insurance
Private investors? group